MedTrace Logo

First Trimester Prediction of Preeclampsia and Fetal Growth Restriction

NCT02379494 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2017-08-22

No results posted yet for this study

Summary

To evaluate the feasibility of screening for preeclampsia and fetal growth restriction between 11-13+6 weeks' gestation utilizing the combination of uterine artery doppler, maternal blood pressure, maternal characteristics, placental volume, and maternal serum factors, including PAPPA-A, PLGF, AFP and free Beta HCG. This is a non interventional study.

Conditions

Sponsors & Collaborators

  • Wright State University

    collaborator OTHER

  • Fetal Medicine Foundation

    lead OTHER

Principal Investigators

  • Jiri D Sonek, MD · Fetal Medicine Foundation/USA

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2017-01-01
Completion
2017-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02379494 on ClinicalTrials.gov